Type 2 Diabetes costs are avoidable with right interventions.
Looking at Marpai’s data, about 6% of members have Type 2 Diabetes, costing self-insured clients 35 million USD. The key insight is that Type 2 Diabetes can be reversed and these costs are avoidable. This represents a significant opportunity for self-insured companies. By using AI and data to match the best intervention to the best use case, we can maximize therapeutic success and improve ROI. At Marpai we evaluated over 60 different healthcare programs to partner with, specifically to address conditions like this where costs are preventable.